Mualliflar

  • Nazirjonov O.X.
  • Abdurahimov A.X.

##semicolon##

COVID-19, buyrak shikastlanishi, o‘tkir buyrak yetishmovchiligi, patogenez, klinik shakllar, morfologik o‘zgarishlar, proteinuriya, gematuriya, SARS-CoV-2, nefropatiya, yallig‘lanish, endoteliy disfunksiyasi, sitokin bo‘roni, virusli nefrit, glomerulyar shikastlanish, nefrotoksiklik.

##submission.citations##

Abdullaev ShS, Igamberdieva RSh, Sharapov ON. Porazhenie pochek pri COVID-19: kliniko-patogeneticheskie aspekty i vedeniye patsientov s khronicheskoy bolezniyu pochek. Klinicheskaya Nefrologiya. 2021;13(1):63-67. https://doi.org/10.185 65/nephrology.2021.1.63-67

Abdurakhimov A, Kakharov Z. Pathogenetic role of coronavirus infection in the development of acute kidney injury. Am J Med Med Sci. 2024; 14(6):1673-1679. https://doi.org/10.5923/j.ajmms. 20241406.44

Abdurakhimov A. K. et al. Analysis of demographic, clinical and laboratory parameters in COVID-19 patients with acute kidney injury //Clinical nephrology. – 2025. – Т. 17. – №. 1. – С. 33-36.

Abdurakhimov A. K. et al. Pathogenesis of kidney injury in COVID-19 and diabetes mellitus: a review of current concepts //Clinical nephrology. – 2025. – Т. 17. – №. 3. – С. 81-84.

Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res. 2020;194:101-115. https://doi.org/10. 1016/j.thromres.2020.06.029

Adamczak M, Surma S, Więcek A. Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatment. Adv Clin Exp Med. 2022;31(3):317-326. https://doi.org/10.17219/ac-em/143542

Baklaushev VP, et al. COVID-19. Etiologiya, patogenezi, diagnostika i lechenie. Klinicheskaya praktika. 2020;11(1):7-20. (In Russ.) https://doi.org /10.17816/clinpract26339

Cheruiyot I, Kipkorir V, Ngure B, et al. Acute kidney injury is associated with worse prognosis in COVID-19 patients: a systematic review and meta-analysis. Acta Biomed. 2020;91(3):19 https:// doi.org/10.23750/abm.v91i3.10222

Drucker DJ. Coronavirus infections and type 2 diabetes—shared pathways with therapeutic implications. Endocr Rev. 2020;41(3):13. https:// doi.org/10.1210/endrev/bnaa011

Garvin MR, Alvarez C, Miller JI, et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. eLife. 2020:16. https://doi.org/10.7554/eLi-fe.59177

Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia–a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14(4):395-403. https:// doi.org/10.1016/j.dsx.2020.04.018

Kiseleva AV, Leskova AV, Skvortsov VV. Patologiya pochek u patsientov s COVID-19. Lechashchiy vrach. 2022;9:19-23. (In Russ.) https:// www.lvrach.ru/2022/09/15438433

Ma M, Wan X, Gao M, et al. Renin-angiotensin-aldosterone system blockade is associated with higher risk of contrast-induced acute kidney injury in patients with diabetes. Aging (Albany NY). 2020; 12(7):5858. https://doi.org/10.18632/aging.10298

Mal'tseva LD, et al. Mekhanizmy ostrogo povrezhdeniya pochek pri Covid-19. Obzor. Nefrologiya i dializ. 2021;23(3):352-365. (In Russ.) https://doi.org/10.28996/2618-9801-2021-3-352-365

Nekaeva ES. Klinicheskoe znachenie pokazateley gemostaza i endotelial'noy disfunktsii u patsientov, perenesshikh novuyu koronavirusnuyu infektsiyu (COVID-19) v pervuyu volnu: dis. kand. med. nauk. Nizhniy Novgorod; 2022:150. (In Russ.)

Shamkhalova MS, Mokrysheva NG, Shestakova MV. COVID-19 and kidneys. Diabetes Mellit. 2020;23(3):235-241. https://doi.org/10.14341/DM 12506

Wang A, et al. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract. 2020;162:2. https://doi.org/10.1016/j. diabres.2020.108118

Wang D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. https://doi.org/10.1001 /jama.2020.1585

Zahid U, et al. Acute kidney injury in COVID-19 patients: an inner city hospital experience and policy implications. Am J Nephrol. 2020; 51(10): 786-796. https://doi.org/10.1159/000511160

Абдурахимов, А. (2023). COVID-19 как триггер в развитии острого почечного повреждения (ОПП) у больных сахарным диабетом. Экспериментальная медицина: сегодня и в будущем, 1(1), 3–4.

Абдурахимов А. Х. и др. Поражение почек у пациентов с covid-19 //Re-health journal. – 2022. – №. 2 (14). – С. 99-106.

Абдурахимов А. Х. и др. Роль сахарного диабета в развитии поражения почек при covid-19 //Re-health journal. – 2022. – №. 2 (14). – С. 107-118.

Абдурахимов А. Х. Патогенез развития поражения почек при covid-19 //Re-health jour-nal. – 2022. – №. 4 (16). – С. 1-5.

Гончаров И. М. и др. Респираторные исходы у пациентов, перенесших covid-19 //Re-health journal. – 2023. – №. 1-2 (17). – С. 1-4.

Кахаров Зафар Абдурахманович, Абдурахимов Абдухалим Холиддин Угли патогенетическая роль коронавирусной инфекции в развитии острого повреждения почек // ejar. 2024. №2-1.